John Moller is the CEO of Novotech, a company recognized in the 2025 Pharmaceutical Technology Excellence Awards.
John Moller is the CEO of Novotech, a company recognized in the 2025 Pharmaceutical Technology Excellence Awards. He has been instrumental in Novotech's growth, particularly its expansion beyond Australia into the broader Asia-Pacific region 17 years ago. Moller focuses on driving scientific innovation, client engagement, and advancing diversity within the company.
Full founder directory · Investor directory · Company funding database · Fundraising library